GNH USA

Europe — EMA

Nuvaxovid Jn.1

Matrix M, Sars-Cov-2, Variant Omicron Jn.1, Spike Protein, Recombinant, Expressed In Sf9 Cells Deriv

Request sourcing

1
Pack/s
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Matrix M, Sars-Cov-2, Variant Omicron Jn.1, Spike Protein, Recombinant, Expressed In Sf9 Cells Deriv
Route
Intramuscular Use
Manufacturer
Novavax Cz A.S.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU